US Supreme Court upholds pharmaceutical executive convictions News
stevepb / Pixabay
US Supreme Court upholds pharmaceutical executive convictions

The US Supreme Court Monday denied a request by pharmaceutical company executives to overturn their convictions. The former executives of Insys Therapeutics were charged with bribing doctors to distribute a fentanyl-based pain medication that the company was selling.

John Kapoor filed a petition with the court back in January claiming that the US Court of Appeals for the First Circuit erred in convicting him. Kapoor claimed that his actions were legal because doctors believed they were acting in good faith when entering into an agreement him.

Kapoor, the founder of Insys Therapeutics, was found guilt of racketeering. In 2019 Kapoor was sentenced to five and a half years in prison for incentivizing the sale of pain medication to people who did not need it by bribing doctors to prescribe the fentanyl spray, Subsys.

Former regional sales director Sunrise Lee was convicted on similar charges; Lee received a conviction of 1 year and a day.

Other members of the company sentenced in 2019 were Vice President Michael Gurry, CEO Michael Babich, Richard Simon and Joseph Rowan.

Lee has completed her sentence.